Associations between insulin-like growth factor I,vascular endothelial growth factor and its soluble receptor 1 in umbilical serum and endothelial cells obtained from normotensive and preeclamptic pregnancies

Abstract

The aim of this study was to investigate the associations between insulin-like growth factor I (IGF-I) with vascular endothelial growth factor (VEGF) and its soluble receptor 1 (sFlt-1) in umbilical serum and to study the effects of IGF-I upon sFlt-1 synthesis in human umbilical vein endothelial cells (HUVEC) in normotensive (NT) and preeclamptic (PE) pregnancies. As compared with the NT group, umbilical serum IGF-I and VEGF levels were lower in the PE group, while sFlt-1 concentrations were higher. Levels of sFlt-1 correlated with IGF-I in the NT group and with VEGF in the PE group. Basal concentration of sFlt-1 in HUVEC culture media was higher in the PE group. IGF-I stimulated sFlt-1 synthesis only in the NT group. In summary, umbilical serum sFlt-1 is associated with IGF-I in normotensive pregnancy and with VEGF in preeclampsia. IGF-I stimulates sFlt-1 synthesis in endothelial cells in normotensive but not in PE pregnancies.     

MK2 plays an important role for the increased vascular permeability that follows thermal injury

We previously reported Rho kinase is involved in vessel hyper-permeability caused by burns. Here we further explore the Rho kinase downstream signaling, it is found that its specific inhibitor Y27632 significantly diminishes the activation of JNK and p38 MAPKs but not ERK that induced by serum from burned rats (burn-serum). JNK activation was found involved in the expression of HUVEC adhesion molecules following thermal injury, although not in the process of stress fiber formation. Inhibition of various MAPKs by specific inhibitors showed that SB203580 (inhibitor of p38), but neither SP600125 (inhibitor of JNK) nor PD98059 (inhibitor of ERK), abolish activation of the p38 downstream kinase MK2. Demonstration of stress fibers by fluorescent-labeled phalloidin showed that inhibition of MK2, either by its specific inhibitor or by dominant negative adeno-viral-carried constructs, significantly reduced burn-serum-induced HUVEC stress-fiber formation, while inhibition of another downstream p38 MAPK kinase, PRAK, had no such effects. Transfection of dominant negative adeno-viral MK2 (Ad-MK2(A)) significantly inhibited thermal injury-induced blood vessel hyper-permeability in rats and, moreover, prolonged the survival of burned rats beyond 72 h following thermal injury. One of the mechanisms behind these phenomena is that Ad-MK2(A) causes a significant depression of burn-serum-induced HSP27-phosphorylation, while the adeno-viral transported dominant negative PRAK (Ad-PRAK(A)) does not block. Although the effect of blockade of MK2 through its adeno-viral approach requires further study and investigation of alternatives to know for sure, we may have found a new pathway behind thermal-injury-induced blood vessel hyper-permeability, namely: Rho kinase > p38 > MK2 > HSP27.     

Markers of early endothelial dysfunction in intrauterine growth restriction-derived human umbilical vein endothelial cells revealed by 2D-DIGE and mass spectrometry analyses

Intrauterine growth restriction (IUGR) associates with fetal and placental vascular dysfunction, and increased cardiovascular risk later on life. We hypothesize that endothelial cells derived from IUGR umbilical veins present significant changes in the proteome which could be involved in the endothelial dysfunction associated to this conditions. To address this the proteome profile of human umbilical endothelial cells (HUVEC) isolated from control and IUGR pregnancies was compared by 2D-Differential In Gel Electrophoresis (DIGE) and further protein identification by MALDI-TOF MS. Using 2D-DIGE 124 spots were identified as differentially expressed between control and IUGR HUVEC, considering a cut-off of 2 fold change, which represented ∼10% of the total spots detected. Further identification by MALDI-TOF MS and in silico clustering of the proteins showed that those differentially expressed proteins between control and IUGR HUVEC were mainly related with cytoskeleton organization, proteasome degradation, oxidative stress response, mRNA processing, chaperones and vascular function. Finally Principal Component analysis of the identified proteins showed that differentially expressed proteins allow distinguishing between control and IUGR HUVEC based on their proteomic profile. This study demonstrates for the first time that IUGR-derived HUVEC maintained in primary culture conditions present an altered proteome profile, which could reflect an abnormal programming of endothelial function in this fetal condition.     

扁塑藤素对LPS诱导的HUVEC细胞功能损伤和焦亡的作用

目的研究扁塑藤素对脂多糖(LPS)诱导人脐静脉血管内皮细胞(HUVEC)损伤的保护作用及可能机制。方法 建立LPS诱导HUVEC损伤模型,HUVEC细胞分为对照组、LPS组以及低、中、高剂量扁塑藤素组(0.1、0.2、0.4 μmol/L扁塑藤素)。CCK-8法测定细胞活力;试剂盒法检测乳酸脱氢酶(LDH)、丙二醛(MDA)、超氧化物歧化酶(SOD)含量;ELISA法检测白细胞介素-1β(IL-1β)、IL-18蛋白水平;蛋白免疫印迹法、实时荧光定量PCR法检测焦亡相关分子NLRP3、Caspase-1、GSDMD蛋白和mRNA表达量。 结果与对照组比较,LPS组细胞活力和SOD含量显著下降(P＜0.05),LDH和MDA含量、NLRP3、Caspase-1、GSDMD的蛋白和mRNA表达量均显著升高(P＜0.05)。扁塑藤素呈剂量依赖性提高细胞活力和SOD含量,抑制LDH、MDA,降低NLRP3、Caspase-1、GSDMD的蛋白和mRNA表达水平(P＜0.05)。 结论扁塑藤素呈剂量依赖性抑制细胞焦亡和减轻氧化应激,从而改善LPS诱导的HUVEC功能损伤。     

Protein kinase C isoforms in atherosclerosis: Pro- or anti-inflammatory?

Atherosclerosis is a pathologic condition caused by chronic inflammation in response to lipid deposition in the arterial wall. There are many known contributing factors such as long-term abnormal glucose levels, smoking, hypertension, and hyperlipidemia. Under the influence of such factors, immune and non-immune effectors cells are activated and participate during the progression of atherosclerosis. Protein kinase C (PKC) family isoforms are key players in the signal transduction pathways of cellular activation and have been associated with several aspects of the atherosclerotic vascular disease. This review article summarizes the current knowledge of PKC isoforms functions during atherogenesis, and addresses differential roles and disputable observations of PKC isoforms. Among PKC isoforms, both PKCβ and PKCδ are the most attractive and potential therapeutic targets. This commentary discusses in detail the outcomes and current status of clinical trials on PKCβ and PKCδ inhibitors in atherosclerosis-associated disorders like diabetes and myocardial infarction. The risk and benefit of these inhibitors for clinical purposes will be also discussed. This review summarizes what is already being done and what else needs to be done in further targeting PKC isoforms, especially PKCβ and PKCδ, for therapy of atherosclerosis and atherosclerosis-associated vasculopathies in the future.     

Discovery of a New Series of Naphthamides as Potent VEGFR-2 Kinase Inhibitors

相似文献   

KIF2C对肝细胞癌细胞恶性生物学行为和人脐静脉内皮细胞血管生成的影响

目的：探究驱动蛋白-13家族2C（KIF2C）对肝细胞癌（HCC）细胞增殖、侵袭和迁移以及人脐静脉内皮细胞（HUVEC）血管生成的影响,为HCC治疗提供潜在靶点。方法：用数据库数据分析KIF2C mRNA和蛋白在HCC组织中的表达及其与血管生成相关因子（VEGFR2 和HIF-1α）表达的相关性,常规培养人正常肝细胞QSG-7701、HUVEC 和HCC细胞Huh-7、Hep3B2.1-7,用 Lipofectamine 3000 转染试剂将 sh-NC 和 sh-KIF2C 转染至 Huh-7、Hep3B2.1-7 细胞,qPCR 检测各组 QSG-7701、Huh-7 和Hep3B2.1-7 细胞中KIF2C mRNA 的表达,WB 法检测各组细胞中KIF2C 蛋白的表达,细胞克隆形成实验检测敲低KIF2C 对Hep3B2.1-7 和Huh-7 细胞克隆形成的影响,小管生成实验检测敲低KIF2C 表达的Huh-7 和Hep3B2.1-7 细胞的条件培养液对HUVEC 血管生成能力的影响。结果：数据库分析结果显示,KIF2C mRNA 和蛋白在HCC 组织中均呈高表达（均P<0.01）,用qPCR 和WB法检测人HCC中KIF2C mRNA和蛋白的表达水平,结果显示其mRNA和蛋白在各HCC 细胞中也呈高表达（均P<0.01）,与数据库数据分析结果相符。数据库数据分析还显示,KIF2C 与HCC组织中VEGFR2、HIF-1α的表达水平呈正相关（P<0.05 或P<0.01）。成功构建了稳定低表达KIF2C 的Huh-7 和Hep3B2.1-7 细胞（均P<0.01）,敲低KIF2C 表达均可明显抑制Huh-7和Hep3B2.1-7细胞的增殖能力（均P<0.01）、侵袭和迁移能力（均P<0.01）,敲低KIF2C表达的HCC细胞条件培养液均可显著抑制体外HUVEC的血管生成能力（P<0.05 或P<0.01）。结论：KIF2C可促进Huh-7和Hep3B2.1-7细胞增殖、侵袭和迁移以及HUVEC血管生成的能力,提示KIF2C可能是治疗HCC的潜在靶点     

17β-雌二醇对氧化型低密度脂蛋白由钙介导细胞骨架损伤的抑制作用

目的　通过观察 1 7β 雌二醇 (1 7β E2 )与氧化低密度脂蛋白 (OX LDL)作用于血管内皮细胞后细胞内微丝肌动蛋白的变化以及同细胞内钙离子变化间的关系 ,以探讨雌激素的血管保护作用机制。方法　采用ECV 30 4脐静脉内皮细胞株体外培养 ,分为空白对照组 ,OX LDL(2 0 0 μg/ml)组 ,4× 1 0 - 7mol/LE2 作用组 ,E2 保护组 ,采用激光扫描共聚焦显微镜分别观察OX LDL作用后 1 2h时的胞内钙离子的变化及OX LDL作用 2 4h时的细胞骨架微丝的改变。结果　OX LDL作用 1 2h后细胞内钙离子浓度明显升高 ,而细胞骨架微丝也在 2 4h后发生明显的破坏。雌激素预处理后可明显抑制OX LDL作用导致后细胞内钙离子浓度的升高 ,并且明显地防止细胞骨架微丝损伤的发生。结论　 1 7β E2 可能通过抑制OX LDL导致的细胞内钙离子升高从而防止细胞骨架微丝损伤的发生 ,这可能是雌激素产生血管保护作用的机制之一。     

汉滩病毒感染诱导血管内皮细胞多糖包被损伤及其机制初步研究

目的 探讨汉滩病毒(hantaan virus,HTNV)感染血管内皮细胞致多糖包被(glycocalyx,GCX)损伤的分子机制.方法 利用HTNV感染人脐静脉血管内皮细胞(human umbilical vein endothelial cells,HUVECs),在感染不同时间段,ELISA检测细胞上清中GCX组...     

Differences in the Effect of Angiotensin-converting Enzyme Inhibitors on the Rate of Endothelial Cell Apoptosis: In Vitro and In Vivo Studies

Aim An imbalance between endothelial apoptosis and regeneration is one of the initiating events in atherosclerosis. Angiotensin-converting enzyme (ACE) inhibition corrects the endothelial dysfunction observed in coronary artery disease, and this could be the consequence of a reduction in the rate of endothelial apoptosis. The aim of this study was to investigate the effect of different ACE inhibitors on endothelial apoptosis. Methods We examined the effect of five ACE inhibitors (enalapril, perindopril, quinapril, ramipril, and trandolapril) on the rate of endothelial apoptosis, either in vitro in human umbilical vein endothelial cells (HUVECs), using a serum deprivation method to induce apoptosis, or in vivo in rats, inducing apoptosis via endotoxic shock with Escherichia coli lipopolysaccharides (LPS). Results We were unable to detect any significant effect of ACE inhibition on the rate of in vitro endothelial apoptosis at concentrations ranging from 5 × 10⁻⁸ to 10⁻⁶ M. In contrast, chronic in vivo administration of ACE inhibitors to rats at dosages that had similar hypotensive effects reduced the rate of LPS-induced apoptosis significantly for perindopril (P < 0.001) and nonsignificantly for the other ACE inhibitors. The order of potency of the ACE inhibitors tested was perindopril > ramipril ≫ quinapril = trandolapril = enalapril, with significant differences between perindopril and quinapril (P < 0.01), trandolapril (P < 0.001), and enalapril (P < 0.001). The difference between perindopril and ramipril did not reach significance. Conclusion Our experiments suggest differences between ACE inhibitors in terms of inhibition of endothelial apoptosis in vivo.